Survival sepsis campaign recommends that vasopressor therapy is required to maintain mean arterial pressure (MAP) ≥ 65 mmHg. However, the absolute maximum dose of vasopressor is difficult to determine. Herein, we report 2 cases of severe skin necrosis after high dose vasopressor infusion to maintain the recommended MAP in septic shock. In our first case, norepinephrine 1.0-2.0 μg/kg/min and vasopressin 0.03-0.1 U/min were infused for 5 days; in the second case, dopamine 10-20 μg/kg/min and norepinephrine 0.25-2.5 μg/kg/min were infused for 7 days. Severe ischemic skin lesions, which required amputations, developed in both cases. The clinical appearance of the skin lesions in the 2 cases was different because of the unique distribution of target receptors for different vasopressors. Thus, when high dose vasopressors are required to achieve recommended MAP, extra vigilance is required. Further studies for dose adjustment are needed.
An international effort to improve the conditions that arise from severe sepsis and a septic shock resulted in the publish- and calves for two days (Fig. 1A, B) , and ischemic change of both fingers and toes became aggravated (Fig. 1C, D) . After Continuous veno-venous hemodialysis was also applied due to acute kidney insufficiency (AKI).
72 hours after the infusion of vaspressors, he began to show cyanosis at distal areas of both fingers and toes. On the sixth day, dopamine and norepinephrine infusions were discontinued since his septic condition improved. However, ischemic lesion at the distal areas of both fingers and toes were aggravated, eventually leading to the necrosis of the lesions ( Fig. 2A-C) . (Fig. 2D-F) .
Nine months later from his hospital admission, he was discharged. Amputation of all toes caused him a great disturbance in rapid gait, spring, squatting and tiptoeing. Therefore, he had to wear shoe fillers on both feet for the enhancement of resilience and received rehabilitation training afterward.
DISCUSSION
Ischemic skin necrosis is a serious complication in critically ill patients with a high mortality rate (up to 40%) and half of survivors require amputation of affected limbs. This meant that skin lesions were not caused by infection.
Clinical manifestations of skin necrosis in the second case were consistent with previous reports. [5] [6] [7] 9 ] It will be reasonable to assume that skin necrosis was an adverse effect of norepinephrine and vasopressin.
Several studies have reported that the implementation of the Surviving Sepsis Campaign guidelines was associated with a significant decrease in mortality. [13, 14] In Spain, a three-year follow-up quasi-experimental study with a historical comparison group found that achieving ScvO2 ≥ 70% within 6 hours was the only single intervention that maintained the predictive value of survival independently of the other interventions. [13] In another study, there was a statistically significant decrease of odds ratio for mortality in patients who had received corticosteroids and in mechanically ventilated patients whose inspiratory plateau pressure becomes ＜ 30 cmH2O within 24 hours. [14] Treatment of hypotension with fluids and vasopressors were not the interventions independent of lower mortality in the both studies. Their impact on mortality in severe sepsis and septic shock has rarely been studied, which is also classified as a low quality evidence (grade C) in Surviving Sepsis Campaign guideline. [1] It is obvious that hypotension must be corrected for adequate tissue perfusion in septic shock. However, when high dose vasopressors are required to achieve the recommended MAP, especially in patients with ischemic skin necrosis risk factors, extra vigilance is also required. We should closely monitor the signs of inadequate skin perfusion and, if needed, may assess the skin microcirculation using non-invasive techniques such as capillaroscopy, laser Doppler flowmeter, and transcutaneous measurement of oxygen tension. [15] Furthermore, prospective studies are needed to suggest guidelines for dose adjustment of vasopressors in patients with septic shock.
